Moderna, Merck expand mRNA cancer vaccine deal

Moderna Therapeutics Inc. (Cambridge, Mass.) and Merck & Co. Inc. (NYSE:MRK) added Moderna's mRNA-5671 to a

Read the full 169 word article

User Sign In